The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal artificial intelligence (MMAI) model to identify benefit from 2nd-generation androgen receptor pathway inhibitors (ARPI) in high-risk non-metastatic prostate cancer patients from STAMPEDE.
 
Charles Parker
Other Relationship - Artera (Inst)
 
Vinnie Liu
Employment - Artera; Decipher Biosciences
Stock and Other Ownership Interests - Artera; Decipher Biosciences
Research Funding - Artera; Decipher Biosciences
Travel, Accommodations, Expenses - Artera; Decipher Biosciences
 
Larissa Mendes
No Relationships to Disclose
 
Emily Grist
No Relationships to Disclose
 
Rikiya Yamashita
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Danielle Croucher
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Ashwin Sachdeva
Consulting or Advisory Role - Veracyte
Speakers' Bureau - Ipsen
Travel, Accommodations, Expenses - AIRA Matrix
 
Laura Murphy
Research Funding - Astellas Pharma (Inst); Clovis Oncology (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst)
 
Huei-Chung Huang
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Robert Jones
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Elsevier; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech; WebMD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; IPSEN; Janssen; Merck Serono; MSD Oncology; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD; Pfizer
 
Silke Gillessen
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); InnoMedica (Inst); Ipsen (Inst); LinkinVax (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); PeerVoice (Inst); Pfizer (Inst)
Speakers' Bureau - AdMeTech Foundation (Inst); ASCO GU (Inst); Avalere Health (Inst); EPG Health (Inst); ESMO; ESMO (Inst); Intellisphere (Inst); Medtoday Switzerland (Inst); Meister ConCept GmbH (Inst); Orikata (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Group for Clinical Cancer Research (SAKK) (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - Bayer; Gilead Sciences; Intellisphere; Johnson & Johnson/Janssen
Other Relationship - University of Applied Sciences and Arts of Southern Switzerland (SUPSI)
 
Chris Parker
Honoraria - Advanced Accelerator Applications (Inst); Bayer; Clarity Pharmaceuticals; ITM Oncologics; Janssen; Myovant Sciences
Consulting or Advisory Role - Blue Earth Theraputics; Janssen
Speakers' Bureau - Bayer
 
Daniel Berney
No Relationships to Disclose
 
Phuoc Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Dendreon; GenomeDx; Janssen; Lantheus Medical Imaging; Myovant Sciences; Novartis; Noxopharm; Pfizer; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Daniel Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Novartis; Pfizer
Research Funding - Janssen (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN
 
Mahesh Parmar
Other Relationship - Abcodia (Inst); Advanced Accelerator Applications (Inst); Akagera Amgen Aspirin Foundation (Inst); AOA (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Baxter (Inst); Bayer (Inst); BMS US BriBio BandC Group (Inst); Cepheid (Inst); Cipla (Inst); Clovis Oncology (Inst); CSL Behring (Inst); Emergent BioSolutions (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Grifols (Inst); ICON Oncology (Inst); Janssen (Inst); Janssen-Cilag (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Serono (Inst); Micronoma (Inst); Modus Therapeutics (Inst); MSD (Inst); Mylan (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst); SUMVAX (Inst); Synteny Biotechnlogy (Inst); Takeda (Inst); Tibotec (Inst); Transgene (Inst); ViiV Healthcare (Inst); Virco Xenothera (Inst)
 
Noel Clarke
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; ipsen; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen-Cilag; Sanofi
Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca; Janssen-Cilag; Janssen-Cilag
Research Funding - AstraZeneca; Astrazeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi
 
Louise Brown
Research Funding - AstraZeneca (Inst)
 
Nicholas James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Amgen; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Therapeutics; ESSA; Ferring; Janssen-Cilag; Medivation; Merck; Merck Serono; Millennium; Novartis; Novartis; Pfizer; Ventana Medical Systems; Veracyte; Veridex
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sandoz; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Astellas Pharma (Inst); Blue Earth Therapeutics; Janssen (Inst); Novartis; Veracyte
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.; listed as inventor on docetaxel predictive biomarker (Veracyte); listed as inventor on patent related to blood biomarkers (UCL, Cancer Research Horizons)
Travel, Accommodations, Expenses - Abbott Laboratories; Amgen; Arvinas; Astellas Pharma; Astellas Pharma (I); AstraZeneca; Bayer; Bristol Myers Squib (I); ESSA; Ferring; Janssen; Janssen (I); Medivation; Merck Serono; Novartis; Orion Clinical; Pfizer; Propella Therapeutics; Sanofi; Ventana Medical Systems
Other Relationship - Institute of Cancer Research